Electronic Pillbox-enabled SAT Versus DOT for TB Medication Adherence and Treatment Outcomes

NACompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

June 1, 2020

Primary Completion Date

July 31, 2021

Study Completion Date

August 31, 2021

Conditions
Tuberculosis
Interventions
DEVICE

MERM-observed self-administered therapy

The MERM device has an electronic module and a medication container that records adherence, stores medication, emits audible and visual on-board alarms to remind patients to take their medications on time and refill, and enables providers to download the data and monitor adherence. It is manufactured by Wisepill Technologies, South Africa.

Trial Locations (1)

9086

Addis Ababa University, College of Health Sciences, Addis Ababa

All Listed Sponsors
collaborator

Emory University School of Medicine, US

UNKNOWN

collaborator

Armauer Hansen Research Institute, Ethiopia

OTHER

collaborator

Fogarty International Center of the National Institute of Health

NIH

lead

Addis Ababa University

OTHER

NCT04216420 - Electronic Pillbox-enabled SAT Versus DOT for TB Medication Adherence and Treatment Outcomes | Biotech Hunter | Biotech Hunter